M. V. Shumilina

Safety and efficacy of teriflunomide in paediatric multiple sclerosis (TERIKIDS): a multicentre, double-blind, phase 3, randomised, placebo-controlled trial

Tanuja Chitnis, Brenda Banwell, Ludwig Kappos et al. · The Lancet Neurology · 2021 · 78 citations

Neurological Disorder, Medicine, Paediatric Multiple Sclerosis +8

Resilience and vulnerability are dose-dependently related to neonatal stressors in mice

Oleg Granstrem, M. V. Shumilina, Fernando J. Santos et al. · Hormones and Behavior · 2009 · 64 citations

Developmental Biology, Early Life Exposure, Stress +8

COVID-19 Immunopathology and the Central Nervous System: Implication for Multiple Sclerosis and Other Autoimmune Diseases with Associated Demyelination

Marina Boziki, Alexios‐Fotios A. Mentis, M. V. Shumilina et al. · Brain Sciences · 2020 · 51 citations · Full text

Leptomeningeal Contrast Enhancement Is Associated with Disability Progression and Grey Matter Atrophy in Multiple Sclerosis

Gleb Makshakov, N. А. Totolyan, E. Verbitskaya et al. · Neurology Research International · 2017 · 49 citations · Full text

Autoantibodies against opioid or glutamate receptors are associated with changes in morphine reward and physical dependence in mice

Francesca Capone, Walter Adriani, M. V. Shumilina et al. · Psychopharmacology · 2008 · 19 citations

Health Sciences, Psychiatry, Addiction +13